Abstract
Abciximab is a mouse/human chimeric monoclonal antibody fragment and glycoprotein IIb/IIIa inhibitor. As its use increases (in percutaneous coronary
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have